ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10
April 19, 2024 18:08 ET
|
Wish
ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10
Oak Valley Bancorp Reports 1st Quarter Results
April 19, 2024 17:43 ET
|
Oak Valley Community Bank
OAKDALE, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank...
BioNexus Gene Lab Corp. Bersetuju untuk Melabur RM 1.2 juta dalam Ascension Innovation (AISB) untuk Memajukan Inovasi Kesihatan Digital menerusi penerimaan AI dalam Penjagaan Kesihatan
April 19, 2024 17:36 ET
|
BioNexus Gene Lab Corp.
KUALA LUMPUR, Malaysia, April 20, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corporation (NASDAQ: BGLC), peneraju global dalam diagnostik genomik dan teknologi penjagaan kesihatan, mengumumkan...
Millicom (Tigo) share repurchase activity
April 19, 2024 17:30 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, April 19, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 38,891 of its Swedish Depository...
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
April 19, 2024 17:30 ET
|
Celularity Inc.
FLORHAM PARK, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (NASDAQ: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and...
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
April 19, 2024 17:28 ET
|
Wrap Technologies, Inc.
Wrap Technologies Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
April 19, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (“Iovance” or the “Company”), a biotechnology company focused on innovating, developing, and...
ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice
April 19, 2024 17:10 ET
|
ASLAN PHARMACEUTICALS LIMITED
SAN MATEO, Calif. and SINGAPORE, April 19, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative...
Junee Limited Announces Closing of $8 Million Initial Public Offering
April 19, 2024 16:30 ET
|
Junee Ltd
Hong Kong, April 19, 2024 (GLOBE NEWSWIRE) -- Junee Limited (the “Company” or “Junee”), a provider of interior design, fit-out and maintenance services in Hong Kong, today announced the closing of...
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
April 19, 2024 16:30 ET
|
Hepion Pharmaceuticals, Inc.
EDISON, N.J., April 19, 2024 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic...